TNGX - Rega marang bathi kanthi panyesuaian wutah tangotx.com
Tango Therapeutics focuses on R&D, outsourcing drug synthesis to external CMO partners. The company's innovations are based on the synthetic lethality method to combat resistant tumors. High demand for targeted therapy creates potential for future growth in the patient base. The P/E ratio relative to growth expectations confirms this data, with the value stabilizing at 0.00.
Rincian metrik lan analitis perusahaan Tango Therapeutics (TNGX)
- nilai pasar lan prakiraan target analis:
- statistik kapitalisasi pasar:
- data nilai buku modal saham:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Tango Therapeutics|TNGX - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas tangotx.com|TNGX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Tango Pharma|TNGX - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Tango Therapeutics|Likuiditas darurat tangotx.com
- informasi bathi lan kelipatan valuasi:
TNGX - Penghasilan resik|Proyeksi bathi resik Tango Therapeutics|TNGX - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Tango Therapeutics Corp|TNGX - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Tango Pharma|TNGX - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Tango Therapeutics|TNGX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan tangotx.com|TNGX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics
Ringkesan analitik perusahaan:TNGX Tango Therapeutics Inc
The development of targeted oncology drugs based on synthetic lethality allows Tango Therapeutics (TNGX) to avoid price wars, as reflected in the history of the PEG ratio. This metric compares the market multiple with earnings growth: a value below one signals an undervalued asset, distinguishing temporary market skepticism from a systemic business model crisis and indicating the potential for exponential capital growth.
Pesaing Tango Therapeutics
ImmunityBio Inc (IBRX) - Rasio rega marang wutah bathi resik|Immunocore PLC - Pangali rega marang bathi tumrap wutah|Janux Corp (JANX) - Rega marang bathi kanthi panyesuaian wutah|RCUS: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ZYME (zymeworks.com)|IOVA: Pangali PEG|IMTX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Xencor Corp|Pangali rega marang bathi tumrap wutah Compass Therapeutics Corp (CMPX)|Rasio rega marang bathi tumrap wutah Replimune Group, Inc. (REPL)|Pangali rega marang bathi tumrap wutah lyell.com LYEL|Innate Pharma - Pangali rega marang bathi tumrap wutah|Pangali PEG Pyxis Oncology Inc. PYXS|CGEN - Rasio rega marang bathi tumrap wutah|IOBT (IO Biotech Inc.) - Rasio P/E diaturake wutah|Sutro Biopharma, Inc. (STRO) - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah minktherapeutics.com (INKT)|Pangali rega marang bathi tumrap wutah HOWL|IMMX - Rasio rega marang wutah bathi resik|Pangali rega marang bathi tumrap wutah ALXO (ALX Oncology Holdings)|Rasio nilai perusahaan marang wutah bathi CUE|Pangali PEG PDSB (PDS Biotechnology Corporation)|Koefisien bali modal nimbang wutah SONN|MAIA Biotechnology, Inc. - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Liminatus Pharma Inc.|lavatherapeutics.com (LVTX) - Rasio rega marang bathi tumrap wutah|NextCure Corporation - Koefisien bali modal nimbang wutah|LPTX (Leap Therapeutics Inc) - Pangali PEG|Pangali PEG Intensity Tx|Rasio rega marang bathi tumrap wutah Sensei Biotherapeutics (SNSE)|TOVX: Rasio kapitalisasi marang bathi lan wutah|Gritstone bio - Pangali rega marang bathi tumrap wutah|Kineta Corp (KA) - Rega marang bathi kanthi panyesuaian wutah|NEXI: Pangali rega marang bathi tumrap wutah|Turnstone Biologics - Rasio nilai perusahaan marang wutah bathi|VCNX: Pangali PEG|Harpoon Therapeutics Inc (HARP) - Pangali PEG
